Gene therapy in cardiovascular disorder market is estimated to be worth US$ 178 million in 2023 and is projected to reach US$ 1,351.3 million by 2030, growing at a CAGR of 21.1% during the forecast period 2024-2030. This significant growth is driven by factors such as rising prevalence of cardiovascular diseases, increasing investments in gene therapy research and development, and growing...